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Mammalian skeletal muscles are capable of regenera-
tion after injury. Quiescent satellite cells are activated
to reenter the cell cycle and to differentiate for repair,
recapitulating features of myogenesis during embryonic
development. To understand better the molecular mech-
anism involved in this process in vivo, we employed high
density cDNA microarrays for gene expression profiling
in mouse tibialis anterior muscles after a cardiotoxin
injection. Among 16,267 gene elements surveyed, 3,532
elements showed at least a 2.5-fold change at one or
more time points during a 14-day time course. Hierar-
chical cluster analysis and semiquantitative reverse
transcription-PCR showed induction of genes important
for cell cycle control and DNA replication during the
early phase of muscle regeneration. Subsequently,
genes for myogenic regulatory factors, a group of im-
printed genes and genes with functions to inhibit cell
cycle progression and promote myogenic differentia-
tion, were induced when myogenic stem cells started to
differentiate. Induction of a majority of these genes,
including E2f1 and E2f2, was abolished in muscles lack-
ing satellite cell activity after gamma radiation. Regen-
eration was severely compromised in E2f1 null mice but
not affected in E2f2 null mice. This study identifies
novel genes potentially important for muscle regenera-
tion and reveals highly coordinated myogenic cell pro-
liferation and differentiation programs in adult skeletal
muscle regeneration in vivo.
Skeletal muscles are damaged and repaired repeatedly
throughout life. Muscle regeneration maintains locomotor
function during aging and delays the appearance of clinical
symptoms in neuromuscular diseases, such as Duchenne mus-
cular dystrophy (1, 2). This capacity for tissue repair is con-
ferred by satellite cells located between the basal lamina and
the sarcolemma of mature myofibers (3, 4). Upon injury, satel-
lite cells reenter the cell cycle, proliferate, and then exit the cell
cycle either to renew the quiescent satellite cell pool or to
differentiate into mature myofibers (5). Understanding the mo-
lecular mechanism by which satellite cell activity is regulated
could promote development of novel countermeasures to en-
hance muscle performance that is compromised by diseases or
aging.
Both the cell proliferation and differentiation programs are
essential for myogenesis. Mammalian cells escape from quies-
cence (G0) and enter the cell cycle by activating the Cdk
1/Rb/
E2f signaling pathway (6, 7). In general, mitogen stimulation
induces expression and assembly of the G1 cyclin-dependent
kinases (Cdks) (8, 9). Activation of Cdks causes phosphoryla-
tion of the retinoblastoma protein (Rb) (10, 11), leading to
increased activities of a subset of E2f transcription factors
(E2fs) (12) and up-regulation of a variety of E2f-responsive
genes encoding proteins directly involved in DNA replication
and cell cycle progression (13, 14). On the other hand, myogenic
differentiation is controlled by interactions of a network of
myogenic transcription factors (15). Studies of myogenesis dur-
ing embryonic development and in cultured myogenic cell lines
have provided much insight into the functional role of these
transcription factors (16–22). Briefly, paired box proteins
(Pax3 and Pax7) are involved in myogenic cell lineage determi-
nation and specification (21, 23, 24), whereas primary basic
helix-loop-helix myogenic regulatory factors (MRFs), MyoD
and Myf5 (25, 26), and secondary MRFs, myogenin and MRF4
(27, 28), function downstream in terminal differentiation.
MADS box transcription factors, such as myocyte enhancer
factor 2, cooperate with MRFs in muscle-specific gene expres-
sion (29, 30). However, the functional roles of these regulatory
proteins in adult skeletal muscle have not been well defined.
Several animal models of muscle regeneration have been de-
scribed, but there has not been a comprehensive analysis of
gene regulation in any model. In this study, we have taken
advantage of high density cDNA microarray to assess global
gene expression followed by detailed semiquantitative reverse
transcription (RT)-PCR analysis in a mouse skeletal muscle
regeneration model. Expression of some genes directly related
to cell cycle control and myogenic differentiation was compared
in the presence and absence of satellite cell activities. We have
identified genes previously unknown to be regulated during
skeletal muscle regeneration. We have also uncovered differ-
ential functional roles of E2f1 and E2f2 in vivo using mice with
targeted mutations.
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EXPERIMENTAL PROCEDURES
Muscle Injury Model—We modified a previously described muscle
injury model (22) by injecting cardiotoxin into the tibialis anterior (TA)
muscles of 6-week-old male C57BL/6 mice (Harlen). The muscles were
harvested at various times (1, 2, 3, 5, 10, or 14 days) after injection.
Uninjected TA muscles were used as control. 6 h before muscle harvest-
ing, 500 mg/kg bromodeoxyuridine (BrdUrd) was injected intraperito-
neally to label DNA-replicating nuclei. The left TA muscle was har-
vested, fixed in 4% paraformaldehyde, frozen or embedded in paraffin,
sectioned, and stained with hematoxylin and eosin (H&E) or antibodies
against various antigens. Total RNA was isolated from the right TA
muscle using TriPure kit (Roche Molecular Biochemicals). To assess
the contribution of satellite cell activities in global gene expression, we
injected cardiotoxin into TA muscles that had been subjected to 2,200
rads of gamma radiation (31) 24 h earlier. To determine whether in-
duced expression of E2f1 or E2f2 is essential for injury-induced muscle
regeneration, cardiotoxin was injected in TA muscles in mice with
targeted mutation of E2f1 (Jackson Laboratory) or E2f2 allele (kind
gifts from J. R. Nevins).
Indirect Immunofluorescence—8-m frozen or paraffin-embedded
muscle sections were permeabilized in 0.3% Triton X-100 and PBS,
blocked with normal goat serum, and incubated overnight at 4 °C with
rabbit anti-MyoD antibody (1:50, Santa Cruz), rat anti-Mac-1 (1:400,
Serotec), or rat anti-ag 7/4 (1:400, Serotec) in 5% normal goat serum and
PBS. The sections were incubated with fluorescein isothiocyanate-con-
jugated secondary antibody (1:50, Jackson Laboratory) in 5% normal
goat serum and PBS for 30 min at room temperature. To detect BrdUrd
incorporation, the sections were then fixed for 10 min in 2% formalde-
hyde on ice and treated with 2 N HCl for 60 min at 37 °C to denature the
DNA followed by neutralization in 0.1 M borate buffer (pH 8.5). The
sections were then permeabilized in 0.3% Triton X-100 and PBS and
blocked with 1.5% normal horse serum and PBS and incubated over-
night at 4 °C with mouse monoclonal anti-BrdUrd antibodies (1:25,
Roche) in 0.1% bovine serum albumin and PBS followed by an incuba-
tion with biotinylated horse anti-mouse IgG (1:200, Dako) in 1% normal
horse serum and PBS. The biotinylated IgG was detected by application
of fluorescein isothiocyanate and streptavidin (1:50, Vector) and exam-
ined under epifluorescent or confocal microscope.
Transmission Electron Microscopy—TA muscles were fixed in a so-
lution containing 2.5% glutaldehyde, 137 mM NaCl, 2 mM CaCl2, 4 mM
KCl, 100 mM MOPS (pH 7.4) for 24 h, rinsed in the fixation solution
lacking glutaldehyde for 24 h, treated with 1% osmium tetroxide in 100
mM C2H6AsO2Na (cacodylate) for 2 h, stained with 0.5% uranyl acetate
for 2 h, dehydrated in ethanol, and embedded in Spurr’s resin. Thin
sections were cut, collected on 400-mesh copper grids, and stained with
uranyl acetate and lead citrate. Microscopy was carried out using a
JEOL 1200 EX electron microscope at 80 kV.
RNA Isolation and DNA Microarray—A National Institute on Aging
mouse cDNA chip (16,000 bytes) was used for the microarray analysis.
PCR products from cDNA clones prepared by the Caltech Genome
Research Laboratory (date.tree.caltech.edu/local_clones.html) were
spotted onto CMT-GAPS-coated slides (Corning). Probes for microarray
hybridization were generated using 5 g of pooled muscle total RNA
from five mice of the same time point. The RNA was first annealed with
100 pmol of T7-(dT)24 primer (5-GGCCAGTGAATTGTAATACGACT-
CACTATAGGGAGGCGG-(dT)24-3) in 12 l at 70 °C for 10 min. The
first strand cDNA was synthesized at 42 °C for 1 h in the first strand
cDNA buffer containing 50 mM Tris (pH 8.3), 75 mM KCl, 3 mM MgCl2,
10 mM dithiothreitol, 0.5 mM dNTP, and 10 units/l Superscript II
reverse transcriptase (Invitrogen). The second strand cDNA was syn-
thesized at 16 °C for 2 h in the second strand cDNA buffer containing 20
mM Tris (pH 6.9), 90 mM KCl, 4.6 mM MgCl2, 0.15 mM NAD, 10 mM
(NH4)2SO4, 0.2 mM dNTP, 0.07 unit/l Escherichia coli DNA ligase
(New England Biolabs), 0.27 unit/l E. coli DNA polymerase I (New
England Biolabs), and 0.013 unit/l RNase H (Invitrogen). T4 DNA
Polymerase (20 units, Invitrogen) was added and incubated at 16 °C for
5 min. To stop the reaction, 7.5 l of 1 M NaOH and 2 mM EDTA (pH 8.0)
was added, and the sample was heated at 65 °C for 10 min. The cDNA
was extracted with phenol:chloroform:isoamyl alcohol (25:24:1) and
precipitated with ammonium acetate and ethanol. In vitro transcription
was carried out using a T7 Megascript kit (Ambion). To generate a Cy3-
or Cy5-labeled probe, 10 g of amplified antisense RNA and 6 g of
random hexamer primers were annealed in 14 l at 70 °C for 10 min
followed by incubation at 42 °C for 2 h in 50 mM Tris (pH 8.3), 75 mM
KCl, 3 mM MgCl2, 10 mM dithiothreitol, 10 M dATP/dCTP/dGTP, 4 M
dTTP, 13.3 units/l Superscript II reverse transcriptase (Invitrogen),
and 3 l Cy5 or Cy3 dUTP. The probes were purified by filtering
through Microcon-30 filters (Millipore) before hybridization at 42 °C in
a water bath overnight according to the instructions for CMT-GAPS-
coated slides. The slides were scanned with a GenePix 4000A scanner
(Axon Instruments) and analyzed using the GENEPIX PRO 3.0 (Axon
Instruments).
Microarray Data Analysis—The raw data were normalized using a
total intensity normalization method under the assumption that the
total quantities of messages from both channels should be the same.
Briefly, the average fold difference of all elements of the array was
calculated and used as a normalization factor. This normalization factor
was then used to adjust the fold for each gene in the array. We then
eliminated spots that had median intensities less than the mean plus
three times S.D. of the background Cy3 or Cy5 intensity. Once the
normalized data were obtained and lower than background data points
were removed, we processed the data further by removing any gene
element that had not shown a change 2.5-fold at any time point. This
cutoff level was set after we repeatedly tested the reproducibility of the
microarray hybridization and found an average of only 10 gene ele-
ments with changes greater than 2.5-fold (maximal change of 2.8-fold)
among 16,267 elements assayed (0.061%) when unstimulated control
samples were compared (not shown). For clustering analysis, we con-
verted the Cy5:Cy3 ratio to a log ratio (base 2), analyzed with Gene-
Cluster 2.0 available at www-genome.wi.mit.edu, and generated a 4 
4 self-organization map (32).
Semiquantitative RT-PCR—To confirm the microarray findings and
to survey additional genes pertinent to satellite cell proliferation and
differentiation, semiquantitative RT-PCR analysis was performed as
described (22). Each data point was normalized by the abundance of
glyceraldhyde-3-phosphate dehydrogenase mRNA and expressed as a
log2 ratio to the uninjected control in the randomly preassigned time
course group. PCR primer pairs were designed using a Primer3 search
engine at www-genome.wi.mit.edu. The screened genes and the oligo-
nucleotide primer pairs used for each of the genes in this study corre-
sponded to the following nucleotides: glyceraldhyde-3-phosphate dehy-
drogenase, 114–136 and 403–383 (NM_008084); cell division cycle 6
homolog (Saccharomyces cerevisiae) (Cdc6), 203–224 and 927–907
(NM_011799); origin recognition complex, subunit 1 homolog (S. cerevi-
siae) (Orc1), 866–885 and 1238–1219 (NM_011015); Orc2, 2381–2400
and 2780–2761 (NM_008765); minichromosome maintenance-deficient
2 homolog (S. cerevisiae) (Mcmd2), 2580–2599 and 2903–2884
(NM_008564); Mcmd3, 1445–1464 and 1866–1847 (X62154); E2f1,
2030–2050 and 2147–2128 (L21973); E2f2, 8–27 and 140–121
(AA791874); E2f3, 403–422 and 753–733 (AF015948); E2f4, 471–490
and 705–686 (AA050824); E2f5, 441–459 and 744–725 (X86925); E2f6,
42–61 and 239–220 (AW211063); DRTF-polypeptide-1 (DP1), 422–441
and 868–849 (X72310); protein-regulating cell cycle transcription fac-
tor DRTF1/E2f (DP3), 867–887 and 1204–1185 (S79780); Rb, 1608–
1627 and 2089–2068 (M26391); p130, 1882–2003 and 2272–2251
(U50850); p107, 1801–1820 and 2255–2236 (U27177); cyclin D1, 183–
203 and 511–481 (NM_007631); cyclin D2, 732–751 and 1065–1045
(NM_009829); cyclin D3, 981–200 and 1326–1307 (NM_007632); cyclin
E, 858–879 and 1164–1142 (NM_007633); cyclin E2, 52–71 and 423–
403 (NM_009830); cyclin A2, 1002–1022 and 1325–1305 (NM_009828);
cyclin B, 368–387 and 844–825 (X58708); Pax3, 244–263 and 629–610
(NM_008781); Pax7, 126–145 and 450–431 (U20792); MyoD, 671–690
and 1161–1139 (M84918); myogenin (Myog), 470–492 and 850–830
(D90156); Myf5, 504–528 and 761–738 (NM_008656); myogenic factor 6
(Myf6/MRF4), 432–455 and 677–657 (NM_008657); Cdk inhibitor 2B
(p15Ink4b/Cdkn2b), 49–66 and 373–354 (NM_007670); Cdk4 and Cdk6
inhibitor protein (p16Ink4a), 245–264 and 653–634 (L76150); Cdk4 and
Cdk6 inhibitor p18 protein (p18Ink4c), 50–70 and 462–442 (U19596);
Cdk4 and Cdk6 inhibitor p19 protein (p19Ink4d), 340–360 and 732–713
(U19597); Cdk inhibitor 1A (p21Cip1/Cdkn1a), 369–391 and 691–668
(NM_007669); Cdk inhibitor 1B (p27Kip1/Cdkn1b), 87–106 and 430–
410 (NM_009875); tumor suppressor p53 (p53), 930–949 and 1233–
1204 (AF161020); Cdk inhibitor 1C (p57Kip2/Cdkn1c), 903–923 and
1242–1223 (NM_009876); H19 and muscle-specific Nctc 1 (H19), 980–
999 and 1344–1325 (NM_023123); insulin-like growth factor 2 (Igf2),
473–492 and 636–617 (M14951); reduced expression 3 (Rex3/Bex1),
326–345 and 631–612 (NM_009052); colony-stimulating factor 1 (Csf1),
557–576 and 961–942 (NM_007778); 18 S ribosomal RNA, 448–467 and
926–907 (X00686); sequence information for primers for mesoderm-
specific transcript (Peg1/Mest), paternally expressed gene 1 (Peg3/Pw1);
and zinc finger protein Zac1 (Zac1) is from a previous study (33).
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RESULTS
Cardiotoxin Injection in TA Muscle Induces Extensive and
Complete Regeneration—We injected cardiotoxin into the ana-
tomically more confined TA muscles and showed regeneration
in more than 90% of the myofibers (Fig. 1A). In three independ-
ent experiments, similar morphological changes were observed
repeatedly. Histological analysis demonstrated global myofiber
fragmentation and edema at days 1 and 2 after injury. The
number of mononucleated cells/cross-sectional area increased
significantly after cardiotoxin injection with a peak around day
3. This increase in cell number is attributable to both inflam-
matory cell infiltration and proliferation of satellite cells. Myo-
tubes started to appear at day 3 and became more evident at
days 5 and 10 postinjection. Morphology at day 14 postinjection
was not significantly different from that of the uninjected con-
trol muscles except for the presence of central nuclei, a known
hallmark of recent muscle regeneration, in nearly all myofi-
bers. The percent BrdUrd-positive nuclei increased signifi-
cantly at days 2 and 3 after injury (Fig. 1, A and B), indicating
active cell proliferation. These results suggest that cardiotoxin
injection in TA muscle induces extensive and complete regen-
eration, and the regeneration process shifts morphologically
from a phase of proliferation to differentiation at around day 3
after injury.
Satellite Cell Activation and Proliferation Are Essential for
Skeletal Muscle Regeneration—To assess the functional role of
satellite cell activities in skeletal muscle regeneration in vivo,
transmission electron microscopy was performed. As shown in
Fig. 2A, satellite cell activation was apparent as early as 6 h
after the cardiotoxin injection. The activated satellite cells
were often separated from the adjacent myofiber, leaving elec-
tron-lucent gaps and exhibit more abundant cytoplasm and less
condensed heterochromatin compared with quiescent satellite
cells. At days 2 and 3 after injury, as many as seven or eight
pairs of postmitotic satellite cells were often detected in a large
cleft in degenerating myofiber beneath a single basal lamina.
Myotubes with central nuclei and thick and thin filaments of
nascent sarcomeres were apparent at day 5 postinjection. Ad-
jacent to the myotubes were many small, mononucleated cells
with condensed heterochromatin and little cytoplasm and or-
ganelles. These cells were universally in contact with both the
basal lamina and the cell membrane of the growing myofiber
and are likely to represent myogenic precursor cells that have
reverted to a quiescent state. The timing of satellite cell acti-
vation, proliferation, and resumption of quiescence as evi-
denced by the morphological data is in agreement with the
molecular events detected by cDNA microarray and RT-PCR
observations in this study.
Inflammatory cell infiltration, as a part of the physiological
responses to muscle injury, has complicated the analysis of
global gene expression. A key question is how to distinguish
and ascertain the contribution of myoblast proliferation from
inflammatory cell infiltration. Here we performed indirect im-
munofluorescence for detection of BrdUrd incorporation to
mark proliferative cells on control and injured (day 3) muscle
sections. We also stained the same sections for MyoD, Mac-1, or
ag 7/4 as markers for proliferating myoblasts (34, 35), periph-
eral macrophages (36), and infiltrating neutrophils (37), re-
spectively. We predicted that a great portion of MyoD-positive
cells would be positive for BrdUrd staining, and none of the
Mac-1 or ag 7/4-positive cells would be positive for BrdUrd
because cycling myoblasts expresses MyoD prior to terminal
differentiation, whereas peripheral functional macrophages
and neutrophils are terminally differentiated. Normal muscle
sections showed negative results for any above mentioned
staining (not shown). In any given field of a day 3 muscle
section, we estimated that at least 30% of all cells were positive
for MyoD, BrdUrd, or both (Fig. 2B). Consistent with our ex-
pectation, 45% of the MyoD-positive cells (759 cells counted)
were detected positive for BrdUrd, whereas none of the cells
positive for Mac-1 (508 cells counted) or ag 7/4 (114 cells
counted) incorporated BrdUrd. These results provided unam-
biguous evidence that proliferating satellite cells are the main
source of cells directly involved in myogenesis in skeletal mus-
cle regeneration, and inflammatory cells do not proliferate in
injured skeletal muscle. Those cells expressing MyoD, but with
no BrdUrd incorporation, may be the cycling myoblasts in
phases other than S phase of DNA replication. Our BrdUrd
labeling lasted 6 h, which is only a fraction of a normal cell
cycle time (20 h) for normal mammalian cells. It is also
possible that some of these MyoD-positive cells might have
already exited the cell cycle and initiated the differentiation
process. Consistent with this notion is the observation that
many of these cells had strong staining for MyoD, which pro-
motes myogenic differentiation (38).
To evaluate further the role of satellite cell activities in our
model, gamma radiation was used to compromise the prolifer-
ative capacity of muscle stem cells, which have often been used
to determine satellite cell function in skeletal muscle in vivo
(31, 39). We subjected mouse hind limb muscles to 2,200 rads of
gamma radiation 24 h before the cardiotoxin injection. Irradi-
ated TA muscles were not morphologically different from nor-
mal TA muscles (not shown). However, myogenic cell prolifer-
ation and differentiation after cardiotoxin injection were
blocked as indicated by a significantly lower increase in cell
number, very few BrdUrd-positive nuclei at day 3, and the
absence of newly formed myotubes at day 10 after injury (Fig.
2C). To confirm the findings at the molecular level, we per-
formed semiquantitative RT-PCR to quantify transcripts for
Cdc6, myogenin, and p57Kip2; their expression has been
shown previously to be essential for cell proliferation or myo-
genesis (18, 40, 41). Irradiated TA muscles had attenuated or
delayed induction of these transcripts (Fig. 2D), suggesting
that satellite cells play a pivotal role in skeletal muscle
regeneration.
Comprehensive Microarray Analysis Defines Phasic Changes
in Gene Expression and Identify Novel Genes Regulated during
Muscle Regeneration—To investigate global gene expression
during injury-induced skeletal muscle regeneration, cDNA mi-
croarray hybridizations were performed using a National In-
stitute on Aging mouse 16,000-byte cDNA chip. Of 16,267 ele-
ments screened, 3,532 (21.7%) were altered more than 2.5-fold
at one or more time points. A significant number of genes were
altered during the early phase of regeneration before day 5
after cardiotoxin injection as shown by the scatter plots (Fig.
3A). The trend became less evident as regeneration approached
completion by days 10 and 14 after injury. Quantification con-
firmed a phasic change in the number of differentially ex-
pressed genes (2.5-fold change) with a peak around day 2
(2,310 elements, 14.2% of total) and day 3 (2,324 elements,
14.3% of total) after injury (Fig. 3B). By day 14 after cardio-
toxin injection, only 199 gene elements (1.2% of total) showed
differential expression.
The self-organizing map (32) was used to assemble and an-
alyze the data. The clustering procedure groups together cDNA
elements on the basis of their common expression patterns over
the time points. 16 cluster groups were used (Fig. 3C). Fig. 4
shows part of the results of a hierarchical clustering as de-
scribed previously (42), and complete results are presented as
supplemental data (self-organization map in supplemental
data 1 and functional groups in supplemental data 2) in the
Journal of Biological Chemistry on-line. In most cases, redun-
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dant cDNA probe sets were in the same cluster or in clusters
with similar profiles. For example, eight redundant H2A his-
tone family member Z gene elements were clustered in c5, and
seven mouse heat shock protein 86 were clustered in c4 and c8
with a similar expression pattern. These results confirmed the
fidelity of the microarray analysis used in this study. Further-
more, many functionally related genes were clustered together.
For example, 48 gene elements related to energy and metabo-
lism were clustered in c14 (26.8%, total 179 elements). There is
a nearly 4-fold enrichment of these gene elements in this clus-
ter because there are 258 gene elements related to energy and
metabolism in the population (7.3%, total 3,532 elements).
These findings indicate that the assay system is suitable for
detecting genetic regulatory events during muscle regenera-
tion, and we could use the hierarchical cluster analysis to
identify novel genes with expression patterns similar to those
well known functional genes.
To identify novel genes related to myogenic differentiation,
we focused our attention on genes with a peak expression
pattern concurrent with muscle differentiation. For example,
we noticed that three paternally imprinted genes, H19,
p57Kip2, and Rex3/Bex1, and four maternally imprinted genes,
Igf2, Peg1/Mest, Peg3/Pw1, and Zac1, are clustered in c3 and/or
c1. Because genes in these two clusters have peak induction of
mRNA at day 3 or day 5, concurrent with morphological signs
of myogenic differentiation, coordinated induction of these
genes may play important functional roles in muscle differen-
tiation. We also noticed similar induction of bone morphoge-
netic protein-6, growth arrest-specific 7 (Gas-7) and Gas-1
transcripts in c1, all of which encode antagonists to sonic
hedgehog (Shh) signaling pathways. This points to the possible
roles of these antagonists in myogenic differentiation.
Induction of E2f and Cell Cycle Gene Transcripts Marks the
Proliferative Phase of Skeletal Muscle Regeneration—A total of
36 transcripts encoding regulators of cell cycle progression and
DNA replication were clustered in c4 (14 elements), c5 (11
elements), and c8 (11 elements) clusters. One common feature
of the expression profiles of these clusters is their early induc-
tion and peak expression at day 2 or day 3 and declined ex-
pression after day 3 following injury. This is in strong agree-
ment with the morphological finding that active cell
proliferation occurs during the early phase of regeneration. To
confirm the microarray results and obtain comprehensive in-
formation for genes with functions in the proliferation pro-
gram, we performed semiquantitative RT-PCR for transcripts
of DNA replication factors, cyclins, and Rb/E2f/DP transcrip-
tion factors. DNA replication factors (Cdc6, Mcmd2, Mcmd3,
Orc1 and Orc2) and cyclins (cyclin A2, cyclin B, cyclin D1,
cyclin D2, cyclin D3, cyclin E, and cyclin E2) all had an early
induction in mRNA abundance at day 1, peaking around day 2
or day 3, and started to return to the control level after day 3
following injury (Fig. 5, A and B). Because many of these genes
are regulated by Rb/E2f/DP transcription factors (6, 43), it is
desirable to determine which of the Rb/E2f/DP transcription
factors may participate during skeletal muscle regeneration in
vivo. Therefore, we measured Rb (Rb, p107, and p130), E2f
(E2f1, E2f2, E2f3, E2f4, E2f5, and E2f6) and DP (DP-1 and
DP-3) transcripts by semiquantitative RT-PCR (Fig. 5C). Con-
sistent with the microarray data, we observed an initial reduc-
tion of E2f6 after injury and minimal increases in E2f3, E2f4,
l), day 10 (f and m), and day 14 (g and n) postinjection were stained with
H&E (a–g) or anti-BrdUrd antibodies (h–n). The scale bar equals 100
m. B, quantification of BrdUrd-positive nuclei in control and TA
muscles at various times after cardiotoxin injection. Data are presented
as the means from two measurements, each with more than 100 in
randomly selected areas in cross-sections.
FIG. 1. Cardiotoxin injection-induced muscle regeneration in
TA muscle. A, serial sections from control (a and h) and injured TA
muscles at day 1 (b and i), day 2 (c and j), day 3 (d and k), day 5 (e and
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FIG. 2. Satellite cell activities in adult skeletal muscle regeneration. A, satellite cell activity assessed by transmission electron
microscopy. a, a quiescent satellite cell in a control TA muscle, showing characteristically condensed heterochromatin in the nucleus and little
cytoplasmic fraction. The cell lies in close contact between the mature myofiber and the continuous basal lamina (indicated by arrows). b, an
activated satellite cell with pseudopodia, less condensed heterochromatin, and increased cytoplasmic fraction near a degenerating myofiber 6 h
after cardiotoxin injection. There are noticeable spaces between the activated satellite cell and the degenerating myofiber. c, two newly divided
progeny cells after cell division in a regenerating myofiber at day 2 after injury. The heterochromatin in these cells is significantly less dense. d,
a myotube with a central nucleus and two satellite cells (indicated by arrows) at day 5 after cardiotoxin injection. B, assessment of satellite cell,
macrophage, and neutrophil in cell proliferation during skeletal muscle regeneration. Muscle sections were stained for MyoD (a), Mac-1 (e), or ag
7/4 (i) with primary antibodies and fluorescein isothiocyanate-conjugated secondary antibody (green colored images) with a simultaneous staining
for BrdUrd on the same sections (b, f, and j, respectively) with anti-BrdUrd primary antibody followed by rhodamine-conjugated secondary
antibody (red colored images). The merged images are presented at high magnification (c, g, and k) and low magnification (d, h, l) below the single
colored images. Cells positive both for BrdUrd and MyoD are shown in yellow. Scale bars equal 20 m. C, compromised cell proliferation in the
absence of active satellite cells. a, H&E staining of injured TA muscle at day 3 after the cardiotoxin injection. There is a significant accumulation
of mononucleated cells in the injured area. b, H&E staining of injured TA muscle at day 10 after the cardiotoxin injection. Newly formed myotubes
with central nuclei are present uniformly. c, immunofluorescence staining with anti-BrdUrd antibody of injured TA muscle at day 3 after the
cardiotoxin injection, showing active DNA replication as indicated by positive BrdUrd staining. d, H&E staining of injured irradiated TA muscle
at day 3 after the cardiotoxin injection. Compared with injured TA muscle without prior irradiation at the same time point, there is significantly
less accumulation of mononucleated cells. b, H&E staining of injured irradiated TA muscle at day 10 after the cardiotoxin injection showing the
presence of degenerative muscle debris and mononucleated cells with no indication of myotube formation. c, immunofluorescence staining with
anti-BrdUrd antibody of injured irradiated TA muscle at day 3 after the cardiotoxin injection. There are few BrdUrd-positive cells. D, blocked/
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delayed activation of marker genes for cell proliferation and differentiation in irradiated TA muscle. Semiquantitative RT-PCR was performed for
uninjected control (C), at day 3 (d3) or at day 10 (d10) after cardiotoxin in nonirradiated (none-IR) or irradiated (IR) TA muscles. Reactions without
total RNA sample (S) or without reverse transcriptase (R) were used as negative controls.
FIG. 3. Microarray analysis of global gene expression during skeletal muscle regeneration. A, scatter plots for comparison between
control (Cy3 signals) and injured (Cy5 signals) TA muscles for 16,267 gene elements at days 1, 2, 3, 5, 10, or 14 after the cardiotoxin injection. Each
individual dot in a plot represents a data point from a single gene element. Gray dots indicate that the difference between the control and injured
muscles is 2.5-fold. Solid dots indicate that the difference between the control and injured muscles is 2.5-fold. B, quantification of the number
of gene elements that showed 2.5-fold change at various time points. C, self-organization map clusters using the 3,532 regulated expression
profiles. The number of clusters was specified as 16, and an algorithm grouped them into discrete clusters. c0–c15 indicates the cluster number,
and the number in the top middle of each box indicates the number of gene elements in each cluster. Time points are 0, 1, 2, 3, 5, 10, and 14 days,
designated by black dots from left to right, where the 0 time point is the assumed log2 ratio of 0 between control samples. Thick lines represent
the mean expression values, and thin lines represent the standard deviations.
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and E2f5 transcripts, whereas E2f1 and E2f2 were highly in-
duced during the proliferative phase of muscle regeneration
between days 1 and 3 after injury. DP-1 was transiently in-
duced, and DP-3 had a minimal change during regeneration.
Members in the Rb family have distinct expression patterns
from each other. Induction of p107 was concurrent with that of
E2f1, E2f2, and DNA replication factors. Induction of Rb tran-
script is not obvious until day 3 after injury, in agreement with
its role in induction of muscle differentiation, whereas p130
remained almost the same during the entire regeneration proc-
ess. The concurrent induction of genes essential for DNA rep-
lication and cell cycle control with significant induction of E2f1,
E2f2, p107, and DP-1 transcripts promoted us to postulate that
these regulatory proteins are essential for satellite cell prolif-
eration in vivo during muscle regeneration.
Coordinated Expression of Myogenic Factors and Cyclin-de-
pendent Kinase Inhibitors Defines a Transition from Cell Pro-
liferation to Differentiation—Transcripts in c3 and c1 showed
no induction until day 3 and day 5 after injury, respectively
(Fig. 3C). Peak expression of these genes corresponds to muscle
differentiation/maturation defined by morphological analyses.
Many muscle-specific genes or genes that are known to be
induced during skeletal muscle differentiation were grouped in
these clusters. For example, cardiac and slow twitch skeletal
muscle Ca2-ATPase (Atp2a2), slow twitch skeletal muscle
troponin T (Tnnt1), Igf2, nicotinic cholinergic receptor 
polypeptide 1 (Chrna1), fibroblast growth factor receptor 4
(Fgfr4), Peg1/Mest, p57Kip2, cardiac troponin T2 (Tnnt2), H19,
transforming growth factor 1-induced transcript 4 (Tgfb1i4),
nicotinic cholinergic receptor  polypeptide (Chrng), Igf1, myo-
genin and cardiac and slow-twitch skeletal muscle troponin C
(Tncc) were grouped in these two clusters. It is important to
notice that a majority of these transcripts did not show a
significant increase in irradiated muscles 3 days after cardio-
toxin injection, suggesting that up-regulation of these genes
depends on the presence of satellite cell activities. Induction of
these genes defines, at the molecular level, myogenic differen-
tiation that occurs around day 3 in our regeneration model.
To confirm the microarray findings and obtain comprehen-
sive information of myogenic transcription factors and cell cycle
inhibitors, we performed semiquantitative RT-PCR and re-
vealed distinct expression profiles for different myogenic tran-
scription factors and Cdk inhibitors in adult muscle regenera-
tion (Fig. 5, D and E). First, compared with the uninjected
control TA muscle, Pax3 and MRF4 expression showed mini-
mal changes during muscle regeneration. Second, there was an
early induction of MyoD with a peak expression at day 3,
preceding that of Myf5 at day 5 after injury. Third, a sharp
induction was observed for Pax7 and myogenin at day 3 after
injury concurrent with myogenic differentiation. For the Cdk
inhibitors, microarray analysis showed that the p18Ink4c tran-
script was transiently induced during the proliferative phase of
muscle regeneration (in c5), whereas the p57kip2 transcript was
induced during muscle differentiation (in c1 and c3). RT-PCR
analysis confirmed these findings (Fig. 5E). Remarkably, a
highly coordinated peak induction of transcripts for three other
Cdk inhibitors occurred at day 3 after injury, which includes
p16Ink6a, p15Ink4b and p21Cip1, whereas p19Ink4d and
p27Kip1 showed less dramatic changes during the repair
process.
Comparison between Normal and Irradiated Muscle Is Use-
ful in Assessing Satellite Cell Contribution to Changes in Glo-
bal Gene Expression—One of the major limitations of analysis
of global gene expression for an in vivo study is the heteroge-
neity of the composition of the tissue samples. It is difficult to
ascertain which cell population is responsible for the changes
detected in the expression profile. More specifically, we do
know not whether induced or reduced expression of a gene of
interest is a direct result of satellite cell proliferation and
differentiation or of inflammatory cell infiltration. It is cer-
tainly not practical to determine cell-specific expression for all
of the genes surveyed in the microarray hybridization using
any of the exiting morphological analyses. We decided to take
advantage of gamma radiation to eliminate satellite cell activ-
ities in adult skeletal muscle. As we have shown in this study,
FIG. 4. Hierarchical clustering analysis of expression profiles.
A, the genes with distinct transient induction grouped by self-organiz-
ing map in c3 are clustered by correlation of the profiles. Gene names
are plotted along the x axis, with each block representing a time point.
Increases or decreases in mRNA levels are represented as shades of
red and green, respectively. B, part of the genes grouped in c4. The
figures are generated by J-Express (MolMine AS, Bergen, Norway;
www.molmine.com).
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gamma radiation of hind limb muscles at 24 h prior to muscle
injury can successfully eliminate satellite cell activities, block-
ing myogenic cell proliferation and differentiation. We assessed
the global gene expression in irradiated muscles without car-
diotoxin injection, which provides information regarding the
effects of gamma radiation alone, and in irradiated muscles at
day 3 after cardiotoxin injection, which provides background
information regarding altered gene expression in the absence
of satellite cell activity. Among 3,532 elements that were shown
to have more than a 2.5-fold change during the time course, 211
and 1,772 gene elements showed more than 2.5-fold change in
the irradiated muscles without and with injury, respectively
(see supplemental data).
To determine whether this approach is useful in assessing
satellite cell contribution to changes in global gene expression,
we used RT-PCR analysis to compare gene expression between
normal and irradiated samples (Fig. 6). Induction of Csf1
mRNA, a marker for macrophages, was not affected by irradi-
ation, suggesting that inflammatory cell infiltration was not
affected by irradiation. In addition to the gene elements that
had been tested (Cdc6, myogenin, and p57Kip2, Fig. 2D), we
analyzed nine genes (cyclin A2, cyclin B, cyclin D1, p107,
Mcmd2, Mcmd3, MyoD, E2f1, and E2f2) that are related to cell
cycle or myogenesis and had been confirmed to be induced
during regeneration. Induction of all these genes, except for
cyclin D1, was abolished in the irradiated muscles at day 3
after injury. The RT-PCR data are in complete agreement with
the microarray data. The finding on cyclin D1 is not surprising
because a recent study also showed persistent stretch-induced
induction of cyclin D1 in irradiated muscles, suggesting that
cyclin D1 plays additional role other than myogenesis in vivo.
Cluster analysis grouped a subset of imprinted genes with well
known myogenic regulatory factors, such as myogenin. We
postulated that coordinated expression of these imprinted
genes is of importance to myogenic differentiation. To test this
hypothesis, we performed the same analysis for all seven im-
printed genes (H19, Zac1, Igf2, p57kip2, Peg1, Peg3, Rex3) that
had profiles similar to those genes encoding myogenic factors,
such as myogenin. Induction of all these imprinted genes, ex-
cept for H19, were abolished in irradiated muscles after injury.
The reason for not detecting H19 mRNA induction may be that
we did not use the time point (day 5) when H19 was shown to
be significantly induced. Overall, these results further support
our hypothesis that coordinated induction of these imprinted
genes may play pivotal roles in muscle differentiation in vivo.
Therefore, we believe cardiotoxin injection in irradiated muscle
provides valuable background information for assessment of
the contribution of satellite cell activities in global gene expres-
sion in this regeneration model. For this reason, we chose to
present the microarray data from the irradiated muscles along
with the time course data.
Targeted Mutation of E2f1, but Not of E2f2, Compromises
Skeletal Muscle Regeneration—Because both E2f1 and E2f2
are highly induced during skeletal muscle regeneration concur-
rent with many genes related to the control of the cell cycle and
DNA replication, we speculated that they both participated in
regeneration by regulating those genes transcriptionally. To
determine whether E2f1 or E2f2 is required for adult skeletal
coding proteins for DNA replication (A), cyclins (B), Rb/E2f/DP tran-
scription factors (C), myogenic regulatory factors (D), and cyclin-de-
pendent kinase inhibitors (E) as described previously (22). Represent-
ative images are presented for each specific gene element after
Southern blot hybridization of the PCR products with 32P-labeled ran-
dom primers. Quantitative data (n 3) are presented on the left of each
graph. Reactions without total RNA sample (S) or without reverse
transcriptase (R) were used as negative controls.
FIG. 5. RT-PCR analysis of expression profiles for genes re-
lated to cell cycle and DNA replication control and muscle dif-
ferentiation. Semiquantitative RT-PCR was performed for genes en-
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muscle regeneration, we performed cardiotoxin injection in TA
muscles in mice with targeted mutation of E2f1 or E2f2. As
shown in Fig. 7, mice with targeted mutation of E2f2 had a
relatively normal regeneration process compared with wild-
type mice, whereas muscle regeneration was severely compro-
mised in mice with targeted mutation of E2f1. Therefore, we
have confirmed that E2f1, but not E2f2, is essential for muscle
regeneration in vivo.
DISCUSSION
Injury-induced regeneration in mouse skeletal muscle is a
useful model to study satellite cell function in vivo (21, 22, 44).
Here, we modified a previously described animal model (22, 45)
and showed extensive and complete regeneration in vivo as
assessed by morphology, DNA replication, and mRNA expres-
sion profiles. Microarray and semiquantitative RT-PCR analy-
ses and comparison between normal and irradiated muscles in
this regeneration model define new insights into molecular
events important for control of proliferation and differentiation
in satellite cells in vivo.
The ability to assay and analyze a very large number of
genes with respect to mRNA expression using microarray anal-
ysis provides an opportunity to reveal unsuspected functions of
known and novel genes. This technology has recently been used
successfully to study gene regulation in skeletal muscle (46–
52). In this study, we were able to map seven imprinted genes
(Bex1, H19, p57Kip2, Igf2, Peg1/Mest, Peg3/Pw1, and Zac1)
into two transcript clusters with profiles indicative of impor-
tance for muscle differentiation. Four of these genes, H19,
p57Kip2, Peg3/Pw1, and Igf2, have previously been shown to be
regulated during skeletal muscle development (41, 53–55). We
confirmed that the induction of six of these imprinted genes by
muscle injury was abolished in the irradiated muscles, further
supporting the notion that they play important role in satellite
cell activities during muscle regeneration because gamma ra-
diation eliminates satellite cell proliferation and blocks muscle
regeneration. One intriguing question related to these findings
is how these imprinted genes are regulated during the regen-
eration process. The simplistic explanation is that muscle in-
jury enhances monolellic expression of these genes as a result
of increased transcriptional activity. It is also formally possible
that there is an epigenetic reprogramming because epigenetic
modification to DNA or chromatin plays a role in determining
gene activity (56). In another word, these genes begin to ex-
press from the imprinted allele in the injured muscle. Never-
theless, a highly coordinated expression of imprinted genes in
muscle regeneration in vivo has been first noticed in this study.
A comprehensive analysis of expression of imprinted genes
in this model is likely to yield new information regarding
the importance of epigenetic regulation during muscle
regeneration.
A transient induction of bone morphogenetic protein-6,
Gas-7, and Gas-1 transcripts contemporaneous with myogenic
differentiation suggests the importance of these antagonists to
the Shh signal transductions in muscle differentiation. The
Shh signaling pathway is important for the activation of myo-
genesis in mammals (57, 58), and Shh signaling is required for
maintenance of Myf5 and MyoD and for the correct timing of
terminal differentiation in zebrafish development (59). Our
study identifies potential antagonist signaling molecules in
these pathways pertinent to muscle differentiation in vivo.
We employed gamma radiation to cause reproductive death
of satellite cells, which showed no discernible effect on mor-
phology of uninjured muscle. However, this treatment blocked
DNA replication and myotube formation and blocked/delayed
induction of Cdc6, myogenin, and p57Kip2 transcripts, indicat-
ing that satellite cell activation and proliferation are abolished
by gamma radiation. Therefore, cardiotoxin injection in irradi-
ated muscles could provide valuable background information
for assessment of the contribution of satellite cell activities in
global gene expression during skeletal muscle regeneration.
The functional relationship among myogenic transcription
factors in governing myogenic differentiation has been defined
by studies in developing mouse embryos (21, 23–30). Our ob-
servation that an early induction of MyoD transcript during the
proliferative phase of muscle regeneration precedes a sharp
induction of MyoG at differentiation is consistent with a role for
FIG. 6. RT-PCR analysis for a direct comparison between nor-
mal and irradiated muscles before and after cardiotoxin injec-
tion. Semiquantitative RT-PCR was performed for imprinted genes
and genes related to cell cycle control and myogenic differentiation.
Representative images are presented for each specific gene element
after resolving the PCR products on 1.5% agarose gel and staining with
ethidium bromide. Similar results were obtained from three independ-
ent sample sets. Reactions without reverse transcriptase (R) were
used as negative controls.
FIG. 7. E2f1/ mice are defect in muscle regeneration. H&E
staining of TA muscles of wild-type (a–c), E2f1/ (d–f), and E2f2/
(g–i) mice without injury (a, d, and g), at day 3 after injury (b, e, and h),
and at day 10 after injury (c, f, and i). There is no significant morpho-
logical difference in the uninjured TA muscle cross-sections among the
wild-type, E2f1/, and E2f2/ mice. Both the E2f1/ and E2f2/
muscles have less mononucleated cell accumulation at day 3 after the
cardiotoxin injection. At day 10 after injury, only E2f1/ TA muscle
shows little sign of nascent myotube formation and the noticeable
presence of mononucleated cells.
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a MyoD-myogenin cascade in myogenic differentiation. The
expression pattern of MyoD transcripts detected in this study
is also consistent with its multiple functions in myogenic cell
maintenance and differentiation. A unique finding in this study
is the induction of Myf5. Peak expression of Myf5 was not
induced until after the induction of Pax7 and myogenin and
initiation of differentiation, implying that the function of Myf5
and/or its regulation are fundamentally different between em-
bryonic development of skeletal muscle and adult muscle re-
generation. The evidence supporting this hypothesis is the
previous finding that targeted mutation of MyoD leads to nor-
mal skeletal muscle development in association with compen-
satory expression of Myf5 (17), but adult skeletal muscles lack-
ing MyoD gene are defective in muscle regeneration (44, 60).
Because Pax7 is required for the satellite cell lineage specifi-
cation and Myf5 is expressed in quiescent satellite cells (61,
62), we hypothesize that the Pax7-Myf5 cascade plays a coop-
erative role in specifying and renewing the satellite cell pool
during skeletal muscle regeneration in vivo. Collectively, re-
sults from this study suggest that the transcription factors
governing myogenic differentiation play distinct roles during
adult muscle regeneration from that observed during myogen-
esis in embryonic development.
What mechanisms are responsible for coupling cell cycle
withdrawal with muscle differentiation? Proteins that are ca-
pable of inhibiting the cell cycle and promoting myogenesis
may serve such a function. In the present study, we quantified
mRNA expression of all known Cdk inhibitors during muscle
regeneration in vivo. We observed highly coordinated induction
of several transcripts for Cdk inhibitors at the time of myogenic
differentiation, among which p15Ink4b, p18Ink4c and
p16Ink4a are specific inhibitors for Cdk4 and Cdk6 and
p21Cip1, and p57Kip2 are broader Cdk inhibitors. Remark-
ably, p57Kip2 and p21Cip1 are known to be essential for myo-
genesis acting on myogenin (41), and p57Kip2 stabilizes MyoD
by a direct interaction (63) and by inhibition of cyclin E/Cdk2
(64). Similarly, both p16Ink4a and p18Ink4c have also been
implicated in promoting myogenic differentiation independent
of their inhibition of Cdk4 and Cdk6 (65–67). Hence, highly
coordinated induction of Cdk inhibitors may inhibit cell cycle
progression and trigger cell cycle exit, whereas promoting myo-
genesis coordinating regulatory cross-talk between the prolif-
eration and differentiation genetic programs in vivo.
Satellite cell reentry into the cell cycle from quiescence re-
quires activation of the Cdk/Rb/E2f signaling pathway. The
regulatory step that involves E2f transcription factors is criti-
cal in this process because E2f regulates genes involved in DNA
replication and cell cycle progression (7, 14, 68–70). In this
study, we observed transient induction of Cdc6, Orc1, Orc2,
Mcmd2 and Mcmd3 transcripts as well as most of the cyclins
with a pattern similar to transcription factors DP1, p107, E2f1,
and E2f2. This unique combinatory induction of Rb/E2f genes
commits myogenic stem cells in cell cycle during regeneration
in vivo. We are beginning to determine the functional role of
some of these individual members in the control of cell prolif-
eration during muscle regeneration. We wondered whether
both E2f1 and E2f2 are required for muscle injury-induced
satellite proliferation and regeneration. Injection of cardiotoxin
in TA muscles of mice with targeted mutation of E2f1 results in
severely compromised muscle regeneration as indicated by the
persistent presence of degenerative debris and fewer and less
mature myotubes at the late phase of muscle regeneration.
Whether the absence of induction of E2f1 leads to defects in
apoptosis, which in turn leads to defective muscle regeneration,
remains to be ascertained because it has been reported recently
that E2f1 induces apoptosis through a p53-dependent pathway
in mammalian cells (71). The relatively normal regeneration
process in E2f2 null mice is unexpected, but it suggests that
disruption of E2f2 expression alone is not sufficient to cause
retardation of muscle regeneration. Although this study does
not rule out the possibility that the other E2f transcription
factors play fundamentally important roles through different
regulatory mechanisms such as protein phosphorylation and/or
degradation, the results presented here provide direct evidence
that E2f1 and E2f2 play distinct roles in adult skeletal muscle
regeneration.
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